Replimune Group, Inc.
REPLNASDAQHealthcare● Active
$8.97
$-0.50(-5.28%)
Market Cap$740676392
P/E Ratio—
52W High$13.24
52W Low$1.5
Replimune Group, Inc.（REPL）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · REPL · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.48B | $0.42B | $0.58B | $0.40B | $0.48B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.50B | $0.43B | $0.59B | $0.40B | $0.48B |
| PP&E Net | $0.05B | $0.05B | $0.05B | $0.06B | $0.06B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.55B | $0.49B | $0.65B | $0.46B | $0.54B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.00B | $0.01B | $0.00B | $0.00B |
| Total Current Liabilities | $0.06B | $0.04B | $0.03B | $0.02B | $0.01B |
| Long-Term Debt | $0.05B | $0.04B | $0.03B | $0.00B | $0.00B |
| Total Liabilities | $0.14B | $0.11B | $0.09B | $0.05B | $0.04B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.95B) | ($0.70B) | ($0.49B) | ($0.31B) | ($0.19B) |
| Total Stockholders Equity | $0.42B | $0.37B | $0.56B | $0.41B | $0.50B |
| Total Liab & Equity(computed) | $0.55B | $0.49B | $0.65B | $0.46B | $0.54B |
| Debt Summary | |||||
| Total Debt | $0.08B | $0.08B | $0.06B | $0.03B | $0.03B |
| Net Debt | ($0.03B) | $0.00B | ($0.09B) | ($0.07B) | ($0.15B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Replimune Group, Inc.
关于Replimune Group, Inc.（REPL）资产负债表
Replimune Group, Inc.总资产$0.55B，现金及短期投资$0.48B，总负债$0.14B，总债务$0.08B，股东权益$0.42B。
常见问题
REPL · 4 问Replimune Group, Inc.总债务$0.08B，净债务($0.03B)。
REPL total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10